Iris De Bruijn is an accomplished professional in the field of clinical development, currently serving as the Head of Clinical Franchise for Influenza at Sanofi since June 2013. With a strong background that includes roles such as Business Owner at ClinIQ BV and International Director of Clinical Operations at IATEC BV, Iris has extensive experience in overseeing scientific and clinical strategies for vaccine projects globally. Previous positions at Solvay Pharmaceuticals included Head of Global Therapeutic Area Vaccines and Clinical Research Director, where Iris managed all aspects of clinical projects in the vaccines domain. Academic qualifications include a Master of Science in Biomedical Sciences and a PhD in Immunology from Leiden University, complemented by several years of practical experience as a registered nurse.
This person is not in the org chart
This person is not in any teams
This person is not in any offices